Non-linear associations of amyloid-$\beta$ with resting-state functional networks and their cognitive relevance in a large community-based cohort of cognitively normal older adults
Junjie Wu, Benjamin B Risk, Taylor A James, Nicholas Seyfried, David W Loring, Felicia C Goldstein, Allan I Levey, James J Lah, Deqiang Qiu
https://arxiv.org/ab…
“My guess is he is getting Kisunla treatments, a monoclonal antibody drug given by monthly infusions to remove amyloid plaques from his brain. It is given to people with signs of Alzheimer’s who have a family history or other risk factors."
'I Was Thinking the Same Thing!': Trump’s Vanishing Acts Keep Lining Up Too Perfectly—Now the Internet’s Convinced They Know What He’s Been Up To
https://atlantablackstar.com/2025/10/06/trumps-vanishing-acts-keep-lining-up-too-perfectlynow-the-internets-convinced-they-know-what-happens-every-28-days/
Pyk2 plays a critical role in synaptic dysfunction during the early stages of Alzheimer's disease
Quentin Rodriguez (GIN, UGA), Floriane Payet (GIN, UGA), Karina Vargas-Baron (GIN, UGA), Eve Borel (GIN, UGA), Fabien Lant\'e (GIN, UGA), Sylvie Boisseau (GIN, UGA), B\'eatrice Blot (GIN, UGA), Jean-Antoine Girault (IFM - Inserm U1270 - SU, INSERM), Alain Buisson (GIN, UGA)
Alzheimer's Clinical Research Data via R Packages: the alzverse
Michael C. Donohue (for the Alzheimer's Disease Neuroimaging Initiative), Kedir Hussen (for the Alzheimer's Disease Neuroimaging Initiative), Oliver Langford (for the Alzheimer's Disease Neuroimaging Initiative), Richard Gallardo (for the Alzheimer's Disease Neuroimaging Initiative), Gustavo Jimenez-Maggiora (for the Alzheimer's Disease Neuroimaging Initiative), Paul S. Aisen (for the Alzheimer'…